Home/Publication/LYFE to Lead in Healthcare Play
LYFE to Lead in Healthcare Play 

30 Aug 2024

US$ 19.00

LYFE Capital is taking a leading role in the issuance of US$200 million US dollar-denominated European convertible...

Price / article: US$19.00
OR existing subscriber
Related Publications

Creaegis has led the US$45 million Series B funding round for subscription-based employee healthcare provider Onsurity...

The Longreach Group (Longreach) announced the final closing of Longreach Capital Partners 4 (Longreach 4) at ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.